Podcasts about Prostate cancer

Rob Gronkowski and former NFL head coach Bruce Arians stop by to share a sneak peek at their Super Bowl ad aimed at raising awareness and support for prostate cancer screenings. Also, a closer look at a new Common Sense Media report on teenage boys and gambling. Plus, Katherine LaNasa joins to discuss the whirlwind rise in popularity her show ‘The Pitt' has had and what's in store for Season 2. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Listen to this past episode from the Modern Pleasure Podcast where Kim talks to Dr. Jenni and her husband, Daniel Lebowitz on the subject of ED. Daniel explains how ED plagues both the partnership and the man, but how important it is for the penis to be the signal, acting like a lightning rod for your needs, wants, fears and boundaries. Daniel also covers important facts around prostate surgery. See omnystudio.com/listener for privacy information.

Featuring patient case presentations by Dr Fern Anari and Dr Catherine Fahey, with commentary from Dr Matthew D Galsky, including the following topics: AKT inhibitors for PTEN-deficient de novo metastatic hormone-sensitive prostate cancer (0:00) Radioligand-directed therapy for PSMA-positive metastatic hormone-sensitive prostate cancer (8:18) Radiation therapy in combination with enzalutamide for high-risk localized prostate cancer (13:14) CME information and select publications

A diagnosis should never strip a man of strength, vitality, or hope but rather push medicine to think deeper, not narrower. In this episode, Dr. Stephen Petteruti challenges one of the most deeply rooted assumptions in prostate cancer care that testosterone is the enemy. He breaks down low testosterone is often linked to worse outcomes, androgen deprivation can accelerate decline, and emerging data suggests that carefully applied testosterone therapy may disrupt cancer progression while restoring quality of life.Dr. Stephen walks through the science behind bipolar androgen therapy, PSA misconceptions, and the real-world consequences of long-term hormone suppression. Helping men understand trade-offs, ask better questions, and make decisions based on lived experience rather than fear-driven protocols.Listen closely, reflect deeply, and decide how you want to live moving forward. Watch the episode of Prostate Cancer Didn't Kill Testosterone. Doctors Did.Enjoy the podcast? Subscribe and leave a 5-star review.Dr. Stephen Petteruti is a leading Functional Medicine Physician dedicated to enhancing vitality by addressing health at a cellular level. Combining the best of conventional medicine with advancements in cellular biology, he offers a patient-centered approach through his practice, Intellectual Medicine 120. A seasoned speaker and educator, he has lectured at prestigious conferences like A4M and ACAM, sharing his expertise on anti-aging. His innovative methods include concierge medicine and non-invasive anti-aging treatments, empowering patients to live longer, healthier lives.Website: https://www.drstephenpetteruti.com/ Practice: www.intellectualmedicine.com YouTube: https://www.youtube.com/@intellectualmedicine LinkedIn: https://www.linkedin.com/in/drstephenpetteruti/ Instagram: https://www.instagram.com/dr.stephenpetteruti/ Facebook: https://www.facebook.com/dr.stephenpetteruti    Disclaimer:  The content presented in this video reflects the opinions and clinical experience of Dr. Stephen Petteruti and is intended for informational and educational purposes only. It is not medical advice and should not be used as a substitute for professional diagnosis, treatment, or guidance from your personal healthcare provider. Always consult your physician or qualified healthcare professional before making any changes to your health regimen or treatment plan.Produced by https://www.BroadcastYourAuthority.com

We are in Week 2 of our 4-part series on Cancer, the #2 killer in America.  Dr. Prather talks about why Structure-Function Care and Disease Care must work together to get the best outcomes for patients.  In this episode, you'll find out:—How Holistic Integration's Structure-Function approach helps support patients going through Cancer treatments by keeping the body healthy and in homeostasis. —The story of the oncologist who called Dr. Prather about a terminal Prostate Cancer patient to ask what was being done to his patient because his PSA numbers were improving so dramatically. —The importance of Iodine for Breast Cancer and Fibrocystic Breasts  And how it has been shown to be effective for Prostate Cancer, Colorectal Cancer, and other types of Cancer as well. —Why Vitamin D is critical for Cancer and plays a huge role in our immune system.  And how Dr. Prather finds very few patients come in with proper Vitamin D levels.—The reason Dr. Prather refers to distilled water as "Cancer water".  And why you shouldn't drink too much alkaline water because Cancer cells are extremely alkaline.—The herbals that have anti-Cancer properties and are excellent for detoxification and for boosting the immune system. —Why an evaluation of nutritional deficiencies should be done to prevent and fight Cancer.  And why Anemia is something that should be taken seriously and can impact the survival rate from Cancer by 50%.—How Estrogen dominance can kick off Breast Cancer and Uterine Caner in Women.  And how almost all Prostate Cancers come from Estrogen dominance.—The astonishing story of the experiment Dr. Prater did as a student where rats who ate Wonder Bread "lost their hair, couldn't decide what sex they were, ate their young, and society just fell apart."—How Cancer patients who receive Acupuncture have 85% fewer symptoms and their fatigue levels are much les because "Acupuncture recharges the cells in the body".http://www.TheVoiceOfHealthRadio.com*Receive exclusive bonus content as a member of our Voice Of Health Patreon Community:https://www.patreon.com/cw/VoiceofHealthPodcast

In this episode of Moving Medicine Forward, we talk with Earnestine Walker and Ali Manson of ZERO Prostate Cancer about their mission to ensure every man—regardless of background—has access to early detection, support services, and quality care. They break down Blitz the Barriers, ZERO's major initiative targeting disparities in the hardest‑hit communities, and share how programs like ZERO360 and caregiver resources are transforming patient experiences.We also explore how policy advocacy, community partnerships, and patient voices are driving lasting change in prostate cancer outcomes nationwide. This is a powerful look at what equitable care truly requires—and how ZERO Prostate Cancer is helping move medicine forward. 00:00 – Welcome & IntroductionsMeet Earnestine Walker and Ali Manson of ZERO Prostate Cancer and hear about their roles leading patient programs, education, advocacy, and policy.01:00 – ZERO Prostate Cancer's MissionA look at how advocacy, education, awareness, and support guide every decision—and why “for all” is the organization's guiding star.02:00 – The Vision of Equitable CareDiscussion on what practical, equitable early detection and access look like in real communities.03:30 – Introducing Blitz the BarriersWhy ZERO launched its most ambitious initiative ever—and the staggering disparities it aims to confront.05:00 – The Cities Leading the Change A breakdown of the phased rollout across 12 high‑impact cities, from Baltimore to Appalachia.06:00 – Supporting Patients & FamiliesHow programs like ZERO360 and the Caregiver Retreats provide emotional, financial, and navigation support.08:00 – Navigating Financial BarriersThe role of patient navigation and how ZERO360 has delivered millions in financial assistance.09:30 – Advocacy in Action ZERO's long history on Capitol Hill and recent policy pushes to expand access to free prostate cancer screening.11:00 – Empowering Patient VoicesWhy patient stories and lived experiences are essential to driving legislative change.13:00 – Closing the Gap for Black Men & VeteransHow ZERO Prostate Cancer is addressing the needs of the communities most disproportionately impacted.15:00 – Measuring Impact & Expanding ReachWhat ZERO has achieved so far—and how new data strategies will track long‑term change.17:00 – The Power of Partnerships From national organizations to local community groups, how collaboration amplifies ZERO's equity‑driven mission.19:00 – What's Next for ZERO Prostate CancerA look at future goals, including the life-saving vision behind Blitz the Barriers through 2025.

AI for Prostate Cancer Treatment Planning  Host: Mark L. Gonzalgo, MD, PhD, MBA Guest: Wayne G. Brisbane, MD

In this powerful Q&A episode of The Armor Men's Health Show, Donna Lee sits down with board-certified urologist and Urology Specialists of Austin's very own Dr. Lucas Jacomides to tackle two deeply personal listener questions that many men are quietly struggling with.First, a 65-year-old listener asks a question that cuts to the core of men's health advocacy: Why do we wait for prostate cancer before taking action? With a long history of severe BPH, multiple TURP procedures, bladder incontinence, and a strong family history of cancer, he wants to know how to find a provider who treats the whole person—not just a diagnosis. Dr. Jacomides breaks down the medical reasoning, explores proactive options, and explains how patients can advocate for care that aligns with their quality-of-life goals.Next, the conversation turns to Peyronie's Disease—what it is, how it affects men physically and emotionally, and the real-world treatment options available today. Dr. Jacomides offers a clear, compassionate explanation of how he approaches this condition with patients and what expectations should look like moving forward.This episode is packed with insight, education, and reassurance for men who want answers—and for partners who want to better understand the challenges men face. If you're looking for honest conversations and expert guidance on men's health, this is one you won't want to miss.

In this podcast, experts Scott T. Tagawa, MD, MS, FASCO, FACP; Himisha Beltran, MD; and Neeta Pandit-Taskar, MD, MBA, discuss the latest evidence on PSMA PET and RLT, including combination strategies, selection, sequencing, toxicity monitoring, and operations, with careful attention to access and equity.

Even after a serious diagnosis, men can still pursue decisions that protect the life they want to live. In this episode, Dr. Stephen Petteruti addresses metastatic prostate cancer with a focus on what truly shapes outcomes after the disease has spread. He explains why castration resistance often determines prognosis, how conventional pathways can accelerate decline, and why alternative strategies like bipolar testosterone therapy aim to disrupt cancer biology while supporting vitality.Survival benefit must be weighed against real-world cost. Dr. Stephen walks through chemotherapy, advanced hormone blockade, radioactive therapies, and genetic-targeted drugs, translating statistics into months lived and quality preserved. The emphasis stays on informed choice and realistic expectations.Value clarity over coercion and vitality over hollow promises. Tune in to the episode of Metastatic Prostate Cancer: What Actually Matters After the Cancer Has Spread.Enjoy the podcast? Subscribe and leave a 5-star review on your favorite platforms.Dr. Stephen Petteruti is a leading Functional Medicine Physician dedicated to enhancing vitality by addressing health at a cellular level. Combining the best of conventional medicine with advancements in cellular biology, he offers a patient-centered approach through his practice, Intellectual Medicine 120. A seasoned speaker and educator, he has lectured at prestigious conferences like A4M and ACAM, sharing his expertise on anti-aging. His innovative methods include concierge medicine and non-invasive anti-aging treatments, empowering patients to live longer, healthier lives.Website: https://www.drstephenpetteruti.com/Practice: www.intellectualmedicine.comYouTube: https://www.youtube.com/@intellectualmedicineLinkedIn: https://www.linkedin.com/in/drstephenpetteruti/Instagram: https://www.instagram.com/dr.stephenpetteruti/Facebook: https://www.facebook.com/dr.stephenpetterutiMen's Vitality Community:  https://www.intellectualmedicine.com/membership Consult with Dr. Petteruti: https://www.intellectualmedicine.com/consultation Provider training:  https://www.imeduniversity.com/provider-growth-experienceYouTube: https://www.youtube.com/@intellectualmedicine Instagram: instagram.com/intellectualmedine Disclaimer:  The content presented in this video reflects the opinions and clinical experience of Dr. Stephen Petteruti and is intended for informational and educational purposes only. It is not medical advice and should not be used as a substitute for professional diagnosis, treatment, or guidance from your personal healthcare provider. Always consult your physician or qualified healthcare professional before making any changes to your health regimen or treatment plan.Produced by https://www.BroadcastYourAuthority.com 

In this podcast, the Brian, Tm and David Einstein discuss the EMBARK study and its implications for patients with biochemically relapsed prostate cancer. They explore the criteria for high-risk patients, the role of PSMA PET imaging, and the findings related to metastasis-free survival and overall survival. The conversation also delves into treatment strategies, adverse events, and patient perspectives on treatment decisions, ultimately highlighting the need for future research in this evolving field.

As men and their loved ones explore treatment options for prostate cancer, it's encouraging to know that ongoing innovation is shaping the management of this condition as technology advances. Today, we have the privilege of speaking with Dr. Mark Hong, a pioneer of an advanced treatment for men with prostate cancer and/or BPH, known as Transurethral Ultrasound Ablation, or TULSA. It is a minimally invasive MRI-guided procedure that destroys cancerous tissue while minimizing side effects. We're thrilled to partner with Profound Medical to introduce today's special guest. Dr. Hong is a board-certified urologist at Integrative Urology in Phoenix, Arizona, and a pioneer of MRI-guided TULSA-PRO incision-free surgery for prostate cancer. He completed his urology residency at Harvard Medical Center and earned selection as a national CAPTURE Scholar in prostate cancer. That allowed him to lead projects alongside world-leading scientists from the Dana-Farber Cancer Institute and the University of California, San Francisco. He also completed a fellowship in robotic and minimally invasive surgery at George Washington University in Washington, DC. He has published in almost every major international urology journal, having authored publications on topics ranging from prostate cancer detection to healthcare policy. Dr. Hong joins us today to share more about TULSA-PRO for men with prostate cancer. Having completed over 200 procedures, he has performed more TULSA procedures as an independent urologist, in the absence of a radiologist, than any other urologist in the world. Stay tuned for more! Disclaimer: The Prostate Health Podcast is for informational purposes only. Nothing in this podcast should be construed as medical advice. By listening to the podcast, no physician-patient relationship has been formed. For more information and counseling, you must contact your personal physician or urologist with questions about your unique situation. Show Highlights: Dr. Hong clarifies what the TULSA procedure is How the TULSA procedure differs from other technologies, in terms of its delivery, advantages, and outcomes Who are the ideal candidates for the TULSA procedure? The potential risks associated with the TULSA procedure What patients undergoing the TULSA procedure can expect How the development of new technologies leads to better outcomes for men with prostate cance Links:  Follow Dr. Pohlman on Twitter and Instagram - @gpohlmanmd.  Get your free What To Expect Guide (or find the link on our podcast website)   Join our Facebook group  Follow Dr. Pohlman on Twitter and Instagram  Sign up for the Prostate Health Academy   You can access Dr. Pohlman's free mini-webinar, where he discusses his top three tips to promote men's prostate health, longevity, and quality of life here. Podcast Partner: Profound Medical TULSA-PRO: https://tulsaprocedure.com/     

AUA Guidelines: Salvage Therapy for Prostate Cancer Host: Mark L. Gonzalgo, MD, PhD, MBA Guest: Yaw Nyame, MD, MS, MBA Morgan TM, Boorjian SA, Buyyounouski MK, et al. Salvage therapy for prostate cancer: AUA/ASTRO/SUO guideline part I: introduction and treatment decision-making at the time of suspected biochemical recurrence after radical prostatectomy. J Urol. 2024;211(4):509-517. https://www.auajournals.org/doi/10.1097/JU.0000000000003892 Morgan TM, Boorjian SA, Buyyounouski MK, et al. Salvage therapy for prostate cancer: AUA/ASTRO/SUO guideline part II: treatment delivery for non-metastatic biochemical recurrence after primary radical prostatectomy. J Urol. 2024;211(4):518-525. https://www.auajournals.org/doi/10.1097/JU.0000000000003891 Morgan TM, Boorjian SA, Buyyounouski MK, et al. Salvage therapy for prostate cancer: AUA/ASTRO/SUO guideline part III: salvage therapy after radiotherapy or focal therapy, pelvic nodal recurrence and oligometastasis, and future directions. J Urol. 2024;211(4):526-532. https://www.auajournals.org/doi/10.1097/JU.0000000000003890

Progress in medicine works best when it brings clarity especially when new prostate cancer treatments promise precision.In this episode, Dr. Stephen Petteruti takes a clear-eyed look at focal therapy and asks the question that matters most: does treating part of the prostate actually change long-term outcomes? He explains the difference between FDA clearance and true cancer effectiveness and how cancer biology challenges the idea of isolated “spot treatment.”The conversation breaks down laser ablation, HIFU, cryotherapy, and TULSA. Dr. Stephen also outlines why careful monitoring and whole-body strategies often protect health and vitality more reliably than localized procedures.Choose care that aligns with long-term health, not short-term promises. Watch the full episode of Focal Therapy for Prostate Cancer: Does It Actually Work?Enjoy the podcast? Subscribe and leave a 5-star review.Dr. Stephen Petteruti is a leading Functional Medicine Physician dedicated to enhancing vitality by addressing health at a cellular level. Combining the best of conventional medicine with advancements in cellular biology, he offers a patient-centered approach through his practice, Intellectual Medicine 120. A seasoned speaker and educator, he has lectured at prestigious conferences like A4M and ACAM, sharing his expertise on anti-aging. His innovative methods include concierge medicine and non-invasive anti-aging treatments, empowering patients to live longer, healthier lives.Website: https://www.intellectualmedicine.com/ Website: https://www.drstephenpetteruti.com/ Men's Vitality Community: https://www.intellectualmedicine.com/membership Consult with Dr. Petteruti: https://www.intellectualmedicine.com/consultation Provider training: https://www.imeduniversity.com/provider-growth-experience YouTube: https://www.youtube.com/@intellectualmedicine Instagram: instagram.com/intellectualmedine Disclaimer:  The content presented in this video reflects the opinions and clinical experience of Dr. Stephen Petteruti and is intended for informational and educational purposes only. It is not medical advice and should not be used as a substitute for professional diagnosis, treatment, or guidance from your personal healthcare provider. Always consult your physician or qualified healthcare professional before making any changes to your health regimen or treatment plan.Produced by https://www.BroadcastYourAuthority.com 

Coffee With Scott Adams Moves To The Scott Adams School~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Chat With Scott Adams, Greg Gutfeld, Gus Gutfeld, Dr. Drew, Shelly Adams, Prostate Cancer's Survival Instinct, Minnesota Protest Theatrics, Iran Protests, Liberal White Women, Tyrus President Trump, Consciousness Concept, Dr. Hines, Owen Gregorian, AI Impacts Online Trust, Jack Posobiec, Two Movies One Screen, Scott Adams~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~If you would like to enjoy this same content plus bonus content from Scott Adams, including micro-lessons on lots of useful topics to build your talent stack, please see scottadams.locals.com for full access to that secret treasure.

If you're 55, 60, 65+ and dealing with low energy, low libido, ED, or you've been told testosterone therapy (TRT) is dangerous for prostate cancer—this episode is for you. Dr. Geo sits down with Dr. Abraham Morgentaler (Harvard-trained), founder of the first comprehensive Men's Health Center in the U.S., co-founder of the Androgen Society, author of the bestseller Testosterone for Life, and winner of the 2024 Grandmaster in Testosterone Award.In this conversation, Dr. Morgentaler explains how the old “testosterone causes prostate cancer” dogma took hold, why it's being challenged, and what men should understand today about:✅ TRT and prostate cancer (past, present, and what's changing)✅ Why FREE testosterone matters more than total testosterone for symptoms✅ The importance of listening to patient symptoms, not just “a number”✅ Testosterone options: injections, gels/creams, pellets, oral testosterone✅ What men should ask their doctor if they have low testosterone, active surveillance, or history of prostate cancer treatmentThis episode is educational and designed to help you walk into your next doctor's visit with better questions and clearer understanding.⏱️ CHAPTERS00:00 — TRT + prostate cancer: the myth that won't die01:00 — Who is Dr. Abraham Morgentaler (why he matters) 04:00 — The Harvard lizard lab: how testosterone shaped his thinking10:00 — Pre-Viagra era + why he started testing testosterone in men18:00 — The turning point: finding prostate cancer in men with low T21:00 — Where the dogma came from (Huggins) + why it stuck 27:00 — Why younger men may be seeing lower testosterone (obesity, plastics, more)34:00 — Testosterone in advanced/metastatic prostate cancer: real cases + quality of life40:00 — BAT explained: bipolar androgen therapy (high/low testosterone cycling)45:00 — What patients should do today (TRT after treatment, ADT tradeoffs)51:00 — The “twin” story: why stopping TRT often makes no sense53:00 — Free testosterone vs total testosterone (what to focus on)01:02:00 — TRT options: injections vs gels vs pellets vs oral 01:08:00 — Where to find Dr. Morgentaler + final takeaways

Broadcast from KSQD, Santa Cruz on 1-01-2025: An emailer asks about omega-3 supplementation for memory at age 72. Dr. Dawn advises checking that fish oil capsules contain adequate DHA—at least 1,000 mg—since many omega-3 products have low DHA levels. She notes Medicare covers the same testing at standard labs as proprietary labs like OmegaQuant that charge patients directly. Beyond omega-3s, she emphasizes glucose control (hemoglobin A1c below 5.6) since the enzyme that breaks down insulin also clears beta-amyloid, and weight training to raise brain-derived neurotrophic factor (BDNF), which promotes new synapse formation essential for memory. Dr. Dawn reviews Popular Science's top 2025 health innovation: eye drops from Lens Therapeutics containing aceclidine that correct age-related farsightedness for 10 hours. The drops shrink the pupil to increase depth of field, improving near vision by three or more lines on eye charts within 30 minutes without affecting distance vision. Side effects include eye irritation, dimmed night vision, and headache. She describes Duke University's breakthrough allowing heart transplants from circulatory death donors using an on-table reanimation technique. This could expand the pediatric donor pool by 20%—critical since up to 20% of children die waiting for transplants. Dr. Dawn celebrates CAR-T immunotherapy for multiple myeloma, which saved her husband's life. Of 97 heavily pretreated patients, 38% achieved complete remission still present at five years, with over 50% total survival. The therapy removes T-cells, uses CRISPR to add receptors targeting cancer cell antigens, then reinfuses the modified cells. She highlights a UC Davis study showing remote blood pressure monitoring with home technology, education, and coaching dropped patients' average blood pressure from 150/80 to 125/74 in months—low-tech with high impact. Dr. Dawn explains the Nano Knife for prostate cancer, which uses localized electrical pulses delivered through thin wires to destroy tumors while sparing surrounding nerves. This minimally invasive approach could reduce erectile dysfunction and incontinence common with traditional surgery. She describes Gilead's Sunlenca, a twice-yearly injection for HIV prevention that's 99% effective. At $14,000 per injection in the US, proceeds help fund access in resource-limited countries where it can be distributed like a vaccination. Dr. Dawn discusses Journavx (suzetrigine), a new non-opioid pain medication working on sodium channels to block pain signals before reaching the brain. At $30 for 50 pills on GoodRx, it offers an alternative for surgical pain in patients with addiction history or genetic vulnerability to opioid dependence. She details the landmark case of Baby KJ, the first person to receive personalized CRISPR gene therapy. Born with a CPS1 enzyme deficiency causing toxic ammonia buildup, KJ was too small for liver transplant. Scientists identified his specific mutation and used CRISPR base editing delivered via lipid nanoparticles to correct a single DNA letter—changing an A to G—in his liver cells which restored enough function to be discharged home. Dr. Dawn reports surprising findings that COVID mRNA vaccines amplify cancer immunotherapy. Lung cancer patients who received COVID vaccination within 100 days of checkpoint inhibitor treatment had 56% three-year survival versus 31% for unvaccinated patients. The mechanism is unknown but may involve mRNA generally alerting the immune system. She revisits research showing Zostavax shingles vaccination reduced dementia risk by 20% over seven years. A natural experiment in Wales—where an age cutoff created comparable vaccinated and unvaccinated groups—provided strong evidence that preventing herpes zoster inflammation protects brain health. Dr. Dawn concludes with Huntington's disease breakthrough: microRNA therapy delivered by virus directly into the brain slowed disease progression by 75% over three years. The microRNA binds to Huntington protein mRNA, preventing ribosome translation and toxic protein production. Some patients returned to work; others expected to need wheelchairs are still walking.

If you're 55, 60, 65—and struggling with low energy, poor erections, low libido, or you've been told testosterone is “dangerous” because of prostate cancer, this episode may change how you see the entire topic.Dr. Geo sits down with Dr. Abraham Morgentaler, the Harvard-trained urologist whose work helped overturn the decades-old dogma linking testosterone therapy to prostate cancer risk.Dr. Morgentaler is the founder of the first comprehensive Men's Health Center in the U.S., co-founder of the Androgen Society, author of the bestselling book Testosterone for Life, and winner of the 2024 Grandmaster in Testosterone Award. With 35+ years of clinical experience and 200+ published papers, he shares what the science actually says—plus what men can do practically when talking with their doctors.In this conversation you'll learn:Why the testosterone–prostate cancer fear began (and why it lasted so long)Why low testosterone is often associated with higher-grade prostate cancerWhy free testosterone matters more than total testosterone for symptomsWhat the “Twin Story” reveals about the flawed logic in stopping TRT after treatmentThe role and tradeoffs of androgen deprivation therapy (ADT)How and why some advanced prostate cancer protocols now include testosterone (BAT)How to think through TRT delivery options: injections, gels, oral meds, pelletsWhy testosterone is declining in younger men (obesity, body comp, microplastics)

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/BQU865. CME/MOC/AAPA/IPCE credit will be available until January 2, 2027.Innovative Approaches in Prostate Cancer: Bridging Genomics and Patient-Centric Treatment In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and ZERO Prostate Cancer. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent educational grants from Astellas and Pfizer, Inc., AstraZeneca, Bayer HealthCare Pharmaceuticals Inc., Johnson & Johnson, and Novartis Pharmaceuticals Corporation.Disclosure information is available at the beginning of the video presentation.

Don't miss this incredible opportunity to be informed, inspired, and empowered! On Tuesday morning, Physician-Scientist Dr. Velva Boles will visit our classroom to shed light on some of the most urgent health challenges facing our nation today. Dr. Boles will reveal crucial insights about the new flu strain that is putting our elderly at risk, the alarming measles outbreak, and the dramatic changes to childhood vaccine recommendations. Your questions and concerns will be addressed directly—this is your chance to get expert advice that could protect you and your loved ones. Before Dr. Boles, Health Advocate Pamela Boyce Simms will energize us with a vital discussion about a Prostate Cancer and Men’s Health project happening this week. Kicking off the session, Former NY Lawmaker Charles Barron will break down the far-reaching consequences of the Maduro arrest, offering a perspective you won’t hear anywhere else.See omnystudio.com/listener for privacy information.

Dr. Otis Brawley of Johns Hopkins shares his insight about cancer screening, focusing on prostate cancer. Dr. Brawley explains that while prostate cancer is common and serious, evidence supporting routine PSA screening is limited and inconsistent, leading major organizations to recommend shared decision-making between doctors and patients rather than universal screening. Men of Northwestern Sub-Saharan African ancestry have higher risk, but outcomes are equal across groups when high-quality care is provided, highlighting that disparities stem mainly from access to care, not biology. He emphasizes the importance of individualized screening decisions, treatment at strong medical centers, and patient engagement, and briefly describes Johns Hopkins' MAPS peer-support program for cancer patients.

Prostate cancer that spreads to the bone does not automatically mean surrendering vitality or choice.In this episode, Dr. Stephen Petteruti explains why standard treatments for prostate cancer bone metastasis often miss the mark. He breaks down how aggressive testosterone suppression can ease symptoms in the short term, yet frequently leads to fatigue, weakness, and limited long-term benefit. Dr. Stephen presents a more intentional path forward, one that prioritizes quality of life alongside disease control. He discusses why repeated biopsies and invasive interventions may do more harm than good, and how strategies such as symptom-guided care, intermittent therapy, and carefully considered testosterone approaches may help preserve energy, cognition, and sexual health.Rethink what effective treatment means and engage with an approach centered on living well, not simply enduring. Watch the full episode of Prostate Cancer Bone Metastasis: Why Standard Treatment Fails Men and What to Do Instead.Enjoy the podcast? Subscribe and leave a 5-star.Dr. Stephen Petteruti is a leading Functional Medicine Physician dedicated to enhancing vitality by addressing health at a cellular level. Combining the best of conventional medicine with advancements in cellular biology, he offers a patient-centered approach through his practice, Intellectual Medicine 120. A seasoned speaker and educator, he has lectured at prestigious conferences like A4M and ACAM, sharing his expertise on anti-aging. His innovative methods include concierge medicine and non-invasive anti-aging treatments, empowering patients to live longer, healthier lives.Website: www.intellectualmedicine.com Website: https://www.theprostateprotocol.com/ YouTube: https://www.youtube.com/@intellectualmedicine LinkedIn: https://www.linkedin.com/in/drstephenpetteruti/ Instagram: instagram.com/intellectualmedine Consultation: https://www.theprostateprotocol.com/book-a-consultation Store: https://www.theprostateprotocol.com/store Community: https://www.theprostateprotocol.com/products/communities/v2/fightcancerlikeaman/home    Disclaimer:  The content presented in this video reflects the opinions and clinical experience of Dr. Stephen Petteruti and is intended for informational and educational purposes only. It is not medical advice and should not be used as a substitute for professional diagnosis, treatment, or guidance from your personal healthcare provider. Always consult your physician or qualified healthcare professional before making any changes to your health regimen or treatment plan.Produced by https://www.BroadcastYourAuthority.com 

In this podcast, Brian and Tom engage with Pedro Barata to discuss the emerging field of bispecific T cell engagers and antibody-drug conjugates (ADCs) in the treatment of prostate cancer. They explore the promising data surrounding these therapies, the challenges faced in clinical trials, and the implications of phase three studies. The discussion also touches on the comparative development of ADCs in prostate cancer versus bladder cancer, highlighting the unique challenges and opportunities in each area. The conversation concludes with reflections on the future of these therapies and the potential for combination strategies to enhance treatment efficacy

Guest: Jim Governale Support the show

In this Huberman Lab Essentials episode, my guest is Dr. Kyle Gillett, MD, a dual board-certified physician in family medicine and obesity medicine and an expert in optimizing hormone levels to improve overall health. We explain how to improve hormone levels across the lifespan in both men and women using behavioral, nutritional and exercise-based tools. We also discuss common clinical topics, including hormone testing, PCOS, hair loss, testosterone replacement therapy (TRT) and peptides, focusing on potential benefits, tradeoffs and risks. Read the episode show notes at hubermanlab.com. Thank you to our sponsors AG1: https://drinkag1.com/huberman Maui Nui: https://mauinuivenison.com/huberman Function: https://functionhealth.com/huberman Timestamps (00:00:00) Kyle Gillett (00:00:36) Hormone Health; Women vs Men, Tool: Hormone Testing (00:02:35) Tool: Big 6 Lifestyle Pillars to Optimize Hormone Health (00:04:32) Sponsor: AG1 (00:06:17) Diet, Individualization; Bloodwork & Frequency (00:07:20) Exercise, Zone 2 Cardio; Caloric Restriction (00:08:36) Intermittent Fasting, Growth Hormone, IGF-1 (00:11:05) Hormones & Sleep, Growth Hormone, Menopause, Andropause, TRT (00:13:28) Testosterone & Women, SHGB (00:15:19) Sponsor: Maui Nui (00:16:34) Dihydrotestosterone (DHT), Androgens; Turmeric & Black Pepper; Hair Loss (00:19:47) Polycystic Ovarian Syndrome (PCOS), Symptoms, Metformin, Inositol (00:23:13) Cannabis, Alcohol, Testosterone (00:24:48) Males & Testosterone, TRT, Prostate Cancer (00:26:04) Prolactin, Dopamine "Wave Pool", Tool: Casein & Gluten (00:27:23) Sponsor: Function (00:29:03) Social Relationships & Hormones, Tool: Planning for Crisis (00:31:02) Peptides, Growth Hormone & Risk; BPC 157, Sourcing & LPS (00:36:42) Melanotan, Uses & Risks (00:38:45) Spiritual Health, Interdisciplinary Health Integration (00:41:23) Caffeine & Hormones, Sleep; Acknowledgements Disclaimer & Disclosures Learn more about your ad choices. Visit megaphone.fm/adchoices

Interventional physiatrist Francisco M. Torres discusses his article, "A doctor's own prostate cancer recovery." He shares his vulnerable story of undergoing a robot-assisted radical prostatectomy and the unexpected shame and "erosion of dignity" caused by severe urinary incontinence. Francisco explains how his medical assumption that anatomical knowledge would ensure a fast recovery was wrong, and how pelvic floor physical therapy with biofeedback finally restored his function. The conversation advocates for a systemic shift toward "prehabilitation," arguing that men should start pelvic floor training weeks before surgery rather than being sent home with a pamphlet and diapers. Our presenting sponsor is Microsoft Dragon Copilot. Want to streamline your clinical documentation and take advantage of customizations that put you in control? What about the ability to surface information right at the point of care or automate tasks with just a click? Now, you can. Microsoft Dragon Copilot, your AI assistant for clinical workflow, is transforming how clinicians work. Offering an extensible AI workspace and a single, integrated platform, Dragon Copilot can help you unlock new levels of efficiency. Plus, it's backed by a proven track record and decades of clinical expertise, and it's part of Microsoft Cloud for Healthcare, built on a foundation of trust. Ease your administrative burdens and stay focused on what matters most with Dragon Copilot, your AI assistant for clinical workflow. VISIT SPONSOR → https://aka.ms/kevinmd SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended

Thank you for listening to the Stories That Heal Podcast. Please enjoy our Holiday Replays while we take some time to enjoy the holidays! __________ Chuck Keels was diagnosed with stage 4 prostate cancer in May of 2015. He has an amazing story of a divine interaction as part of his healing story. Chuck is a published author, Tedx speaker, 700 Club interviewee and the world's best hugger. He is the founder of Living Hope Cancer Foundation where positive mindset coaching is his primary focus.  Connect with Chuck... visit getupandlive.org https://www.facebook.com/chuck.keels For more information about Living Hope Cancer Foundation visit -  https://www.facebook.com/LHcancerfoundation  https://www.instagram.com/livinghopecancerfoundation/ https://www.youtube.com/@LivingHopeCancerFoundation https://www.tiktok.com/@chuckkeels To read one of Chuck's books visit - https://www.getupandlive.org/books __________ To learn more about the 10 Radical Remission Healing Factors, connect with a certified RR coach or join a virtual or in-person workshop visit www.radicalremission.com.   To watch Episode 1 of the Radical Remission Docuseries for free, visit our YouTube channel here.  To purchase the full 10-episode Radical Remission Docuseries visit Hay House Online Learning. To learn more about Radical Remission health coaching with Liz or Karla, Click Here Follow us on Social Media: Facebook  Instagram YouTube _______________

There is now a significant opportunity to improve the safety and quality of life outcomes for men requiring treatment for prostate cancer.  Today, we're discussing the Water IV Prostate Cancer trial, an innovative and meaningful clinical trial that is actively enrolling patients to assess how the safety and efficacy of Aquablation therapy compares with radical prostatectomy in men with localized prostate cancer. I'm excited to share my experience as a current investigator for that study and to have Dr. Inderbir Gill, the co-principal investigator from the University of Southern California, join us.  Dr. Gill is the current Chairman and Distinguished Professor of Urology of the University of Southern California Department of Urology. He is also the Founding Executive Director of the USC Institute of Urology. Stay tuned to learn who qualifies as a candidate to participate in the trial, how the study works, and how you can get involved. Disclaimer: The Prostate Health Podcast is for informational purposes only. Nothing in this podcast should be construed as medical advice. By listening to the podcast, no physician-patient relationship has been formed. For more information and counseling, you must contact your personal physician or urologist with questions about your unique situation.  Pertinent disclosure for today's episode – Today's episode is sponsored by PROCEPT BioRobotics Corporation, which manufactures and sells the Aquablation system. Dr. Pohlman is also a paid advisor for PROCEPT BioRobotics Corporation. Show Highlights: How the Water IV Prostate Cancer trial compares Aquablation directly with radical prostatectomy How the Water IV Prostate Cancer trial is the first prospective, randomized U.S. trial comparing a novel prostate cancer treatment to radical prostatectomy. Who qualifies as an eligible participant for the Water IV Prostate Cancer trial? The requirements for those participating in the Water IV Prostate Cancer trial How the trial randomizes the participants in the trial What the study measures as its primary and secondary endpoints  How recruitment for the trial has exceeded all expectations When the early trial results should come out  Links:  WATER IV Prostate Cancer Study webpage: water4pca.com Contact the study team: wateriv@procept-biorobotics.com Aquablation Therapy website: https://aquablation.com/ Follow Dr. Pohlman on Twitter and Instagram - @gpohlmanmd  Get your free What To Expect Guide (or find the link on our podcast website)   Join our Facebook group  Follow Dr. Pohlman on Twitter and Instagram  Sign up for the Prostate Health Academy   You can access Dr. Pohlman's free mini-webinar, where he discusses his top three tips to promote men's prostate health, longevity, and quality of life here.  

Silke details the 2025 prostate cancer highlights

Send us a textSeason 3 Episode 17Welcome back to Who's Tom & Dick. In this episode, Patrick and Martin finally sit down together for a proper catch-up since Martin's return home from hospital. It's a conversation that's been a long time coming — honest, unfiltered, and rooted in real life.Martin shares how the past days have been since coming home: the small wins, the ongoing challenges, and what recovery actually looks like away from the hospital ward. Patrick and Martin reflect on the physical and emotional realities of navigating long-term and life-changing health conditions, speaking openly about Multiple Sclerosis, Arthritis, Strokes, and Prostate Cancer — topics that affect so many families, yet are still too often whispered about or avoided altogether.This episode isn't about medical jargon or scare stories. It's about lived experience, resilience, and the importance of talking — properly talking — about health, vulnerability, and support. There are moments of reflection, moments of honesty, and moments where laughter becomes just as important as the conversation itself.And because it wouldn't be Who's Tom & Dick without ending on a high, the episode wraps up with a bit of festive warmth, Christmas cheer, and the return of a firm favourite… Martin's Joke of the Week — proving once again that even in the face of serious challenges, humour still has its place.So make yourself comfortable, grab a brew, and join us for a heartfelt, hopeful, and very Who's Tom & Dick Christmas catch-up.www.whostomanddick.com#HeartTransplant#eatingdisorder#RareCondition#HealthJourney#LifeChangingDiagnosis#MentalHealth#Vulnerability#SelfCompassion#PostTraumaticGrowth#MedicalMiracle#BBCSports#Inspiration#Cardiology#Surgery#Podcast#Healthcare#HeartHealth#MedicalBreakthrough#EmotionalJourney#SupportSystem#HealthcareHeroes#PatientStories#CardiologyCare#MedicalJourney#LifeLessons#MentalWellness#HealthAwareness#InspirationalTalk#LivingWithIllness#RareDiseaseAwareness#SharingIsCaring#MedicalSupport#BBCReporter#HeartDisease#PodcastInterview#HealthTalk#Empowerment#Wellbeing#HealthPodcast#prostatecancer#Aid's#prostateCheck out our website at www.whostomanddick.comCheck out our website at www.whostomanddick.com

"The thought of recurrence is also a psychosocial issue for our patients. They're being monitored very closely for five years, so there's always that thought in the back of their head, 'What if the cancer comes back? What are the next steps? What am I going to do next?' It's really important that we have conversations with patients and their families about where they're at, what we're looking for, and reassure them that we'll be with them during this journey and help them through whatever next steps happen," ONS member Clara Beaver, DNP, RN, AOCNS®, ACNS-BC, manager of clinical education and clinical nurse specialist at Karmanos Cancer Institute in Detroit, MI, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about prostate cancer survivorship considerations for nurses. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by December 19, 2026. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to survivorship nursing considerations for people with prostate cancer. Episode Notes  Complete this evaluation for free NCPD. ONS Podcast™ episodes: Episode 390: Prostate Cancer Treatment Considerations for Nurses Episode 387: Prostate Cancer Screening, Early Detection, and Disparities Episode 201: Which Survivorship Care Model Is Right for Your Patient? Episode 194: Sex Is a Component of Patient-Centered Care ONS Voice articles: APRNs Collaborate With PCPs on Shared Survivorship Care Models Exercise Before ADT Treatment Reduces Rate of Side Effects Frank Conversations Enhance Sexual and Reproductive Health Support During Cancer Here Are the Current Nutrition and Physical Activity Recommendations for Cancer Survivors Nursing Considerations for Prostate Cancer Survivorship Care Regular Physical Activity and Healthy Diet Lower Risk of All-Cause and Cardiac Mortality in Prostate Cancer Survivors Sexual Considerations for Patients With Cancer Sleep Disturbance Is Part of a Behavioral Symptom Cluster in Prostate Cancer Survivors ONS course: Essentials in Survivorship Care for the Advanced Practice Provider Clinical Journal of Oncology Nursing articles: A Patient-Specific, Goal-Oriented Exercise Algorithm for Men Receiving Androgen Deprivation Therapy Incorporating Nurse Navigation to Improve Cancer Survivorship Care Plan Delivery Prostate Cancer: Survivorship Care Case Study, Care Plan, and Commentaries The Role of the Advanced Practice Provider in Bone Health Management for the Prostate Cancer Population Oncology Nursing Forum articles: A Qualitative Exploration of Prostate Cancer Survivors Experiencing Psychological Distress: Loss of Self, Function, Connection, and Control Identification of Symptom Profiles in Prostate Cancer Survivors Sleep Hygiene Education, ReadiWatch™ Actigraphy, and Telehealth Cognitive Behavioral Training for Insomnia for People With Prostate Cancer Understanding Men's Experiences With Prostate Cancer Stigma: A Qualitative Study Other ONS resources: Late Effects of Cancer Treatment Huddle Card Survivorship Care Plan Huddle Card Survivorship Learning Library American Cancer Society (ACS): Living as a Prostate Cancer Survivor ACS prostate cancer survivorship studies To discuss the information in this episode with other oncology nurses, visit the ONS Communities.  To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "Some of the most common late side effects [are] urinary, bowel, and sexual dysfunction issues. For urinary effects, it can include urgency and frequency, some incontinence, or a weak or slow urine stream that frequently bothers the patient after treatment. Bowel effects can happen such as constipation, diarrhea, or inflammation of the rectum, which can lead to bleeding or mucus discharge. And then erectile dysfunction is another side effect that patients with prostate cancer often deal with and have to work with their physicians on, depending on what they want with that function. Fatigue, lymphedema, and skin changes can also occur after treatment." TS 1:40 "If we can catch [prostate cancer] and take care of it at an early stage, overall survival is about 90%. If the disease is localized, it's 99%. If we can take out the prostate, radiate the prostate, we can do something with that—localized, 99% survival rate. If there's regional metastasis, it's about 90%. And if there's distant metastasis, it's about 30% survival." TS 3:55 "Prostate cancer recurs in about 20%–30% of patients within the first five years of initial treatment. ... There's not a lot of research out there that shows what can reduce risk, but what has been shown to be effective is regular exercise, quitting smoking, and eating a healthy diet. ... It's really important for our patients to understand the importance of having follow-up visits so that we can catch a recurrence quickly instead of waiting years down the road. Prostate cancer is usually a slow-growing disease, so if we can pick it up quickly in those revisits, we can start another treatment for the patient." TS 6:00 "Sexuality is not something many people are comfortable discussing, but we really need to talk with patients and let them know that this is normal. It is normal that you may have some sexual dysfunction. It's normal that you may not feel the way you did before. Talk to us about it, let us know where you're at, let us know what your goals are, because there are a lot of things we can do. There are medications we can use for impedance. There are devices and implants available to help the patient to support them and give them whatever their goal is for their sexuality." TS 9:41 "Providing survivorship care plans are important for these patients—something that can be sent off to everyone else that's caring for that patient. You have your primary care physician, urologist, oncologist, the oncology nurse, maybe a navigator, and [others] who are looking into this patient. So, giving that patient a survivor care plan and putting it with their files to include a summary of the treatment received, because most of the time a patient is not going to remember exactly what they received. A suggested schedule for follow-up exams—so again, if a primary care provider is not used to dealing with a patient with prostate cancer, they have something to go off of. A schedule of other tests they may need in the future including screening for other types of cancer. Are they a smoker? Do they need lung screening? Do they need any other screenings related to types of cancers? And then a list of possible late or long-term side effects." TS 15:16 "I think a lot of people know about the long-term sexual effects, but what we don't really talk about is the effect that it has on the patient's self-image. How they define themselves, how they look, their body image, their self-image. It's really important that we continue to discuss it with patients and make them comfortable when discussing their sexuality and their goals for sexuality. They may be having these self-image issues after treatment that they're just not telling us about and that can affect their quality of life." TS 18:38

Featuring perspectives from Dr Terence Friedlander and Dr Rana R McKay, including the following topics: Introduction (0:00) Prostate Cancer (1:44) Urothelial Bladder Cancer (29:18) CME information and select publications

Dr Terence Friedlander from the UCSF Helen Diller Family Comprehensive Cancer Center and Dr Rana R McKay from the UC San Diego Moores Cancer Center summarize the treatment landscape for prostate and urothelial bladder cancer and discuss the implications of clinical findings recently presented at the ESMO Congress 2025.CME information and select publications here.

Fear can turn even measured men into urgent patients and nowhere is that more obvious than in prostate cancer treatment. In this episode, Dr. Stephen Petteruti addresses this fear-driven reflex, reminding men that clarity comes not from panic, but from understanding how the system often uses fear to push unnecessary interventions. He exposes why biopsies, radiation, surgery, and castration therapies are recommended far more often than they are needed. Dr. Stephen explains how medical bias guides many of these decisions, and he highlights major studies like PIVOT and ProtecT trials that show most aggressive treatments don't improve survival, but they do harm vitality and long‑term health. He also breaks down how urgency is manufactured. Prostate cancer is rarely an emergency, and men almost always have time to think, ask questions, and explore options.For anyone sensing pressure to act fast, this episode offers a clear perspective. Tune in here: How Fear Sells Prostate Cancer Treatment.Enjoy the podcast? Subscribe and leave a 5-star review on your favorite platforms.Dr. Stephen Petteruti is a leading Functional Medicine Physician dedicated to enhancing vitality by addressing health at a cellular level. Combining the best of conventional medicine with advancements in cellular biology, he offers a patient-centered approach through his practice, Intellectual Medicine 120. A seasoned speaker and educator, he has lectured at prestigious conferences like A4M and ACAM, sharing his expertise on anti-aging. His innovative methods include concierge medicine and non-invasive anti-aging treatments, empowering patients to live longer, healthier lives.Website: www.intellectualmedicine.com Website: https://www.theprostateprotocol.com/ YouTube: https://www.youtube.com/@intellectualmedicine LinkedIn: https://www.linkedin.com/in/drstephenpetteruti/ Instagram: instagram.com/intellectualmedine Consultation: https://www.theprostateprotocol.com/book-a-consultation Store: https://www.theprostateprotocol.com/store Community: https://www.theprostateprotocol.com/products/communities/v2/fightcancerlikeaman/home    Disclaimer:  The content presented in this video reflects the opinions and clinical experience of Dr. Stephen Petteruti and is intended for informational and educational purposes only. It is not medical advice and should not be used as a substitute for professional diagnosis, treatment, or guidance from your personal healthcare provider. Always consult your physician or qualified healthcare professional before making any changes to your health regimen or treatment plan.Produced by https://www.BroadcastYourAuthority.com 

In Episode 100, Jamie and Matt reflect on a year that fundamentally reshaped how Matt experiences healthcare—as both a patient and a caregiver. Matt shares an update on his active surveillance prostate cancer journey, including lifestyle changes, monitoring, and learning to live with uncertainty.The conversation expands beyond Matt's diagnosis to include the realities of caregiving: navigating a father's dementia and hospice journey, processing anticipatory grief and loss, supporting a teenage daughter through surgery, and helping a mother recover after a stroke. Matt speaks candidly about caregiver burnout, moments of emotional paralysis, and the importance of asking for help.Together, Jamie and Matt explore how grief lingers, how recovery often proves harder than the crisis itself, and why healthcare must focus on what happens after discharge. Episode 100 closes with a powerful reminder: it's okay not to be okay—but it's not okay to face it alone.

A longer, stronger life often begins with one intentional step. Yet the simplest habits are the ones we underestimate most. In this episode, Dr. Stephen Petteruti highlights one remarkable practice that research links to a 61% reduction in prostate cancer mortality rooted in longevity, practicality, and everyday discipline. He walks listeners through the science behind this habit: three hours per week of vigorous walking. He explains how the right type and duration of movement supports immune function, slows cancer progression, and enhances overall vitality. He also breaks down why extreme exercise backfires, why muscle mass and protein intake matter more than people think, and how simple resistance training can strengthen the body's defenses.He offers guidance on how men can maintain strength, confidence, and energy even when navigating elevated PSA levels or prostate cancer diagnoses.Take a moment for your future health and put these principles to work for your longevity. Watch the episode of One Habit That Cuts Prostate Cancer Death Risk by 61%.Enjoy the podcast? Subscribe and leave a 5-star review on your favorite platforms.Dr. Stephen Petteruti is a leading Functional Medicine Physician dedicated to enhancing vitality by addressing health at a cellular level. Combining the best of conventional medicine with advancements in cellular biology, he offers a patient-centered approach through his practice, Intellectual Medicine 120. A seasoned speaker and educator, he has lectured at prestigious conferences like A4M and ACAM, sharing his expertise on anti-aging. His innovative methods include concierge medicine and non-invasive anti-aging treatments, empowering patients to live longer, healthier lives.Website: www.intellectualmedicine.com Website: https://www.theprostateprotocol.com/ YouTube: https://www.youtube.com/@intellectualmedicine LinkedIn: https://www.linkedin.com/in/drstephenpetteruti/ Instagram: instagram.com/intellectualmedine Consultation: https://www.theprostateprotocol.com/book-a-consultation Store: https://www.theprostateprotocol.com/store Community: https://www.theprostateprotocol.com/products/communities/v2/fightcancerlikeaman/home    Disclaimer:  The content presented in this video reflects the opinions and clinical experience of Dr. Stephen Petteruti and is intended for informational and educational purposes only. It is not medical advice and should not be used as a substitute for professional diagnosis, treatment, or guidance from your personal healthcare provider. Always consult your physician or qualified healthcare professional before making any changes to your health regimen or treatment plan.Produced by https://www.BroadcastYourAuthority.com 

To have Dr. Morse answer a question, visit: https://drmorses.tv/ask/   Dr. Morse Q&A - Tumor - Leukemia - Vitamin C - Prostate Cancer and More #815 00:00:00 - Intro 00:00:28 - Tumor - Leukemia - Liposomal Vitamin C  00:07:40 - Stage 4 Prostate Cancer 00:00:28 - Tumor - Leukemia - Liposomal Vitamin C  Is there any circumstance where Dr Morse would recommend using Liposomal Vitamin C? 00:07:40 - Stage 4 Prostate Cancer I would like your help please, I want to know if I guided my nephew correctly.

In this episode, Ashutosh (Ash) K. Tewari, MD, Urologist and Prostate Cancer Specialist and Chairman of the Milton and Carroll Petrie Department of Urology at the Icahn School of Medicine at Mount Sinai, discusses the rise in prostate cancer cases, strategies to reduce treatment-related side effects, and how mobile units are expanding outreach to improve patient access and early detection.

Late-stage prostate cancer diagnoses are on the rise in Canada. According to a recent study, between 2010 and 2021, rates of prostate cancer discovered at Stage 4 increased by about 50 per cent in men aged 50 to 74. In men over the age of 75, rates were up over 65 per cent.There is a simple blood test that can screen for early signs of prostate cancer, called a prostate specific antigen, or PSA test; however, in 2014, Canada recommended against using the PSA for widespread screening. Today, Globe health reporter Kelly Grant explains what this study found and why these guidelines are so highly contested in Canada.Questions? Comments? Ideas? Email us at thedecibel@globeandmail.com Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

About 1 in 8 men will be diagnosed with prostate cancer during their lifetime. Most of the time, diagnosis happens through routine screenings. This episode, we discuss risk factors for prostate cancer, how to get screened and what you can do if you are diagnosed.Follow us on Instagram: @nprlifekitSign up for our newsletter here.Have an episode idea or feedback you want to share? Email us at lifekit@npr.orgSupport the show and listen to it sponsor-free by signing up for Life Kit+ at plus.npr.org/lifekitLearn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

About 1 in 8 men will be diagnosed with prostate cancer during their lifetime. Most of the time, diagnosis happens through routine screenings. This episode, we discuss risk factors for prostate cancer, how to get screened and what you can do if you are diagnosed.Follow us on Instagram: @nprlifekitSign up for our newsletter here.Have an episode idea or feedback you want to share? Email us at lifekit@npr.orgSupport the show and listen to it sponsor-free by signing up for Life Kit+ at plus.npr.org/lifekitLearn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

In this episode, Dr. Ardeshir Rastinehad, Vice Chair of Urology at Northwell's Lenox Hill Hospital and System Director for Prostate Cancer at Northwell Health, discusses emerging trends and breakthroughs in prostate cancer screening, diagnosis, and treatment. He explains the focal therapy process—including cryotherapy—and shares insights on the mission and impact of the Focal Therapy Society.

Nutritional strategies for treating Barrett's EsophagusHow can my uncle mitigate the side effects of his Merkel cell carcinoma therapy?How long can I take strontium?Is beet root powder beneficial for nitric oxide production?

The best water filter?Even more on gadoliniumVagus nerve therapy benefitsWith so many benefits of drinking coffee, should I drink more of it instead of tea?Any update on Barrett's Esophagus?

Geo Espinosa, ND, LAc, CNS, a well-known naturopathic doctor specializing in urological health at NYU Langone Hospital, licensed acupuncturist, and certified Functional Medicine practitioner, discusses prostate health, including the latest advances in prostate cancer treatment and the importance of a balanced approach between natural and conventional medicine. Dr. Espinosa also highlights the upcoming Prostate Cancer Summit 2.0, scheduled for December 13th-17th, a free online event designed to provide comprehensive information on prostate cancer diagnosis, treatment, and management. The conversation covers PSA testing, new diagnostic tools, advanced treatment options like androgen deprivation therapy, and the benefits of exercise and diet in managing prostate health.

Geo Espinosa, ND, LAc, CNS, a well-known naturopathic doctor specializing in urological health at NYU Langone Hospital, and host of the upcoming Prostate Cancer Summit 2.0, scheduled for December 13th-17th, a free online event designed to provide comprehensive information on prostate cancer diagnosis, treatment, and management. 

Today, we'll be tackling the future of prostate cancer care. We'll be reflecting on what prostate cancer care means in practice, how the way we think about the disease is shifting, and must continue to shift in the years ahead. Scientific advances have transformed treatment in recent years, yet the lived reality of prostate cancer still extends far beyond the clinic. The disease reshapes daily life, and may leave men and their families grappling with difficult choices about how best to manage it.  Dr. Güneş Taylor is joined by three key voices at the centre of this story, following the prostate cancer journey from diagnosis through to long-term management, and asking how patients and clinicians can work together to re-think what patient-centred care could mean in the years to come. This episode is brought to you in collaboration with Bayer, part of their Prostate Cancer Perspectives series.  PP-UN-ONC-GB-0168. November 2025 References Bray F, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229-263 (Prostate cancer is the second most common cancer in men and the fifth leading cause of cancer death worldwide) James D, et al. The Lancet Commission on prostate cancer: planning for the surge in cases. Lancet. 2024;403(10437):1683–1722 (Each year, around 1.5 million men are diagnosed and nearly 400,000 lose their lives to the disease.1 And the numbers are rising. Diagnoses are projected to double from 1.4 million annually in 2020 to 2.9 million by 2040) Siegel RL, et al. Cancer statistics, 2022. Ca Cancer J Clin. 2022;72:7–33 (In the U.S., the proportion of men diagnosed with advanced-stage prostate cancer has doubled in recent years, due to increasing incidence of advanced-stage disease and changing guidelines regarding the prostate specific antigen screening test, implemented in the U.S. in 2012) Dodkins J, et al. Geographic, socioeconomic and demographic inequalities in the incidence of metastatic prostate cancer at time of diagnosis in England: a population based evaluation. BMJ Oncology. 2025;4:e000643 (In England, nearly one in five men only receive a diagnosis once their cancer has spread) Calvo-Schimmel A, et al. Supportive care interventions and quality of life in advanced disease prostate cancer survivors: An integrative review of the literature. Can Oncol Nurs J. 2021;31(4):412-429 (Advanced prostate cancer is often associated with long-term challenges leading to greater levels of unmet needs in supportive care) Learn more about your ad choices. Visit podcastchoices.com/adchoices

On this week's news podcast, the former UK prime minister, David Cameron, calls for prostate cancer screening following his diagnosis. But does it really help to know you have the disease? Also, we find out about the DNA composition of the carbon-rich asteroid Bennu, the underlying cause of Santorini's recent earthquakes, and scientists discover where domestic cats came from... Like this podcast? Please help us by supporting the Naked Scientists

About one in eight men will be diagnosed with prostate cancer in their lifetime. What are some diet and lifestyle solutions?